TAYLOR HALL: Open Payments
NPI 1528742004 · BERKLEY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,363 in 66 payments from 13 companies in 2025. Trend: 2023 $468 · 2024 $1,128 · 2025 $1,363
Food & beverage: $1,288Education: $75
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $282 |
| PFIZER INC. | 12 | $247 |
| Janssen Biotech, Inc. | 8 | $206 |
| GENZYME CORPORATION | 6 | $143 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $135 |
| Regeneron Healthcare Solutions, Inc. | 4 | $111 |
| Novartis Pharmaceuticals Corporation | 3 | $76 |
| UCB, Inc. | 2 | $36 |
| Arcutis Biotherapeutics, Inc. | 2 | $33 |
| Amgen Inc. | 1 | $33 |
Products named: DUPIXENT, CIBINQO, SKYRIZI, TREMFYA, ILUMYA, RINVOQ, COSENTYX, Winlevi.
Industry payments across MI — which companies pay providers there.
